arGEN-X Aktie
| 628,20EUR | -20,20EUR | -3,12% |
WKN DE: A11602 / ISIN: NL0010832176
Personal
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 650 | 843 | 1 148 | 1 599 | 0 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,65 | 0,46 | 0,99 | 1,27 | 0,00 |
Bilanz (in Mio. EUR) - Aktiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 2 236 | 2 599 | 3 733 | 4 716 | 5 874 |
| Summe Anlagevermögen | 270 | 337 | 379 | 1 274 | 1 519 |
| Summe Aktiva | 2 506 | 2 937 | 4 112 | 5 990 | 7 393 |
Bilanz (in Mio. EUR) - Passiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 278 | 300 | 403 | 680 | 1 158 |
| Summe Eigenkapital | 2 228 | 2 636 | 3 709 | 5 310 | 6 235 |
| Summe Passiva | 2 506 | 2 937 | 4 112 | 5 990 | 7 393 |
Adresse
| Laarderhoogtweg 25, 1101 EB Amsterdam | |
| Telefon | +31 (76) 303-04-88 |
| Internet | http://www.argen-x.com |
Management
|
Ana Cespedes
Independent Non-Executive Director |
|
Anthony Adam Rosenberg
Independent Non-Executive Director |
|
Arjen Lemmen
Vice President-Corporate Development & Strategy |
|
Beth Delgiacco
VP-Corporate Communications & Investor Relations |
|
Brian L. Kotzin
Non-Executive Director |
|
Camilla Sylvest
Independent Non-Executive Director |
|
Filip Borgions
Chief Technology Innovation Officer |
|
Hemamalini Moorthy
General Counsel |
|
James M. Daly
Independent Non-Executive Director |
|
Joseph Donald deBethizy
Vice Chairman |
|
Karen Massey
Chief Operating Officer |
|
Karl Gubitz
Chief Financial Officer |
|
Luc Truyen
Chief Medical Officer |
|
Marc Schorpion
Global Head-Human Resources |
|
Pamela M. Klein
Independent Non-Executive Director |
|
Peter K. M. Verhaeghe
Non-Executive Chairman |
|
Peter Ulrichts
Chief Scientific Officer |
|
Sandrine Piret-Gérard
Chief Commercialization Officer |
|
Steve E. Krognes
Independent Non-Executive Director |
|
Tim van Hauwermeiren
Chief Executive Officer & Executive Director |